← Open Payments lookup

NILANJAN GAJARE: Open Payments

NPI 1972616191 · KALAMAZOO, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$4,263 in 169 payments from 12 companies in 2025. Trend: 2023 $3,725 · 2024 $3,662 · 2025 $4,263

Food & beverage: $4,051Education: $211
CompanyPaymentsAmount
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)18$741
Neurocrine BioSciences, Inc.26$580
Teva Pharmaceuticals USA, Inc.19$569
Alkermes, Inc.27$556
E.R. Squibb & Sons, L.L.C.24$540
Otsuka America Pharmaceutical, Inc.20$411
Vanda Pharmaceuticals Inc.16$307
Axsome Therapeutics, Inc.5$276
Supernus Pharmaceuticals, Inc.7$119
Lundbeck LLC4$110

Products named: CAPLYTA, INGREZZA, ARISTADA, COBENFY, FANAPT, REXULTI, AUSTEDO XR, Auvelity.

Industry payments across MI — which companies pay providers there.